Every 10-Q that FitLife Brands, Inc. (FTLF) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 10-Q covers the quarterly report filed between annual reports, so if you follow FTLF and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full FTLF filings page.
FitLife Brands, Inc. reported strong top-line growth for the quarter and six months ended June 30, 2026, largely driven by the August 2025 acquisition of Irwin Naturals. Second-quarter revenue rose 65% to $26.5 million, and first-half revenue increased 62% to $51.9 million compared with 2025.
Net income grew 12% in the quarter to $1.9 million but declined 3% year-to-date to $3.7 million as margins compressed. Consolidated gross margin fell to 37.0% in Q2 from 42.8% a year earlier, reflecting Irwin’s lower-margin profile and pressure on the Legacy FitLife portfolio, whose revenue declined 23% in Q2 and 22% for the first half. Irwin contributed $14.1 million of Q2 revenue and is scaling its e‑commerce presence.
FitLife generated $6.1 million of operating cash flow in the first half, up from $3.5 million, and ended June 30, 2026 with $1.1 million in cash, $9.6 million of working capital, and $37.9 million of debt, mainly the Irwin term loan. The company remained in compliance with its financial covenants and reported no material legal proceedings.
FitLife Brands reported strong top-line growth for the quarter ended March 31, 2026, with revenue rising to $25.3 million, up 59% from $15.9 million a year earlier, largely driven by the acquisition of Irwin Naturals. Legacy FitLife revenue declined 22% to $12.5 million as both online and wholesale sales softened, particularly at MRC and GNC.
Gross profit increased to $9.5 million, but gross margin fell to 37.6% from 43.1% as Irwin operates at lower margins. Net income decreased 15% to $1.7 million, or $0.18 basic EPS, reflecting higher SG&A and interest expense from the expanded business and debt structure. Adjusted EBITDA was essentially flat at $3.3 million.
The company ended the quarter with $104.3 million in total assets, including $51.2 million of intangibles and $19.4 million of goodwill, and total liabilities of $58.9 million. FitLife carried $37.6 million on its Irwin term loan and $4.2 million on its revolving credit line, while maintaining positive working capital of $10.8 million and generating $2.5 million of operating cash flow.
FitLife Brands reported third-quarter results and detailed its August acquisition of Irwin Naturals. Q3 revenue was $23,485, up 47% year over year, driven by the Irwin addition and growth at MusclePharm. Net income was $921 with diluted EPS of $0.09.
Gross margin declined to 37.2% from 43.8%, reflecting Irwin’s historically lower margins and a $392 inventory step-up amortization. Operating expenses rose on transaction costs ($820 in Q3). For the nine months, revenue reached $55,548 and net income was $4,686.
FitLife closed the Irwin deal for approximately $42,500, funded by a new $40,625 term loan and $6,000 drawn on a $10,000 revolver, both with SOFR-based rates. Covenants begin with the quarter ending Dec 31, 2025. To manage rate risk, the company entered a swap on Sep 5, 2025 fixing $20,000 notional at 3.39% to Aug 8, 2030. Shares outstanding were 9,391,072 as of Nov 12, 2025.
FitLife Brands reported quarterly revenue of $16.1 million (down 5% year-over-year) and six-month revenue of $32.1 million (down 4%). Net income was $1.75 million for Q2 and $3.77 million year-to-date, both below the prior-year periods as gross profit and margins declined. Cash and restricted cash totaled $1.585 million at June 30, 2025 and working capital was $9.2 million.
After the quarter the company closed a material acquisition of Irwin Naturals for approximately $42.5 million, funded largely by a new $40.625 million term loan and a new $10.0 million revolver; $29.75 million of the new term loan funded the acquisition and $10.875 million retired prior debt. The company implemented a 2-for-1 stock split and the Board authorized a $5.0 million share repurchase program.